4.3. Analysis.
Comparison 4: Dual versus one antiplatelet agent for preventing early recurrence after ischaemic stroke or transient ischaemic attack, Outcome 3: Intracranial haemorrhage
Comparison 4: Dual versus one antiplatelet agent for preventing early recurrence after ischaemic stroke or transient ischaemic attack, Outcome 3: Intracranial haemorrhage